Affymetrix Stock Price, News & Analysis (NASDAQ:AFFX)

$14.01 +0.02 (+0.14 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$13.99
Today's Range$14.00 - $14.05
52-Week Range$8.28 - $16.15
Volume5.03 million shs
Average Volume3.49 million shs
Market Capitalization$1.13 billion
P/E Ratio116.75
Dividend YieldN/A

About Affymetrix (NASDAQ:AFFX)

Affymetrix logoAffymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.

Receive AFFX News and Ratings via Email

Sign-up to receive the latest news and ratings for AFFX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Diagnostics & Testing
Sub-IndustryLife Sciences Tools & Services


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio116.75
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS$0.12
Net IncomeN/A
Net Margins4.24%
Return on Equity4.84%
Return on Assets2.97%


Outstanding Shares80,490,000

Affymetrix (NASDAQ:AFFX) Frequently Asked Questions

What is Affymetrix's stock symbol?

Affymetrix trades on the NASDAQ under the ticker symbol "AFFX."

How were Affymetrix's earnings last quarter?

Affymetrix, Inc. (NASDAQ:AFFX) issued its quarterly earnings results on Wednesday, February, 17th. The scientific and technical instruments company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by $0.02. The scientific and technical instruments company had revenue of $95.60 million for the quarter, compared to analysts' expectations of $93.29 million. Affymetrix had a net margin of 4.24% and a return on equity of 4.84%. During the same quarter in the prior year, the firm posted $0.09 EPS. View Affymetrix's Earnings History.

Who are some of Affymetrix's key competitors?

How do I buy Affymetrix stock?

Shares of Affymetrix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Affymetrix's stock price today?

One share of Affymetrix stock can currently be purchased for approximately $14.01.

How big of a company is Affymetrix?

Affymetrix has a market capitalization of $1.13 billion.

How can I contact Affymetrix?

Affymetrix's mailing address is 3420 Central Expy, SANTA CLARA, CA 95051-0703, United States. The scientific and technical instruments company can be reached via phone at +1-408-7315000.

MarketBeat Community Rating for Affymetrix (AFFX)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  141 (Vote Outperform)
Underperform Votes:  250 (Vote Underperform)
Total Votes:  391
MarketBeat's community ratings are surveys of what our community members think about Affymetrix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Affymetrix (NASDAQ:AFFX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Affymetrix (NASDAQ:AFFX) Consensus Price Target History

Price Target History for Affymetrix (NASDAQ:AFFX)

Affymetrix (NASDAQ:AFFX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/3/2016Cantor FitzgeraldReiterated RatingHold$14.00N/AView Rating Details
3/23/2016BTIG ResearchReiterated RatingNeutralN/AView Rating Details
(Data available from 2/24/2016 forward)


Affymetrix (NASDAQ:AFFX) Earnings History and Estimates Chart

Earnings by Quarter for Affymetrix (NASDAQ:AFFX)

Affymetrix (NASDAQ AFFX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/17/2016Q415$0.11$0.09$93.29 million$95.60 millionViewN/AView Earnings Details
10/28/2015Q315$0.08$0.10$88.04 million$86.50 millionViewListenView Earnings Details
7/29/2015Q215$0.07$0.12$88.61 million$89.00 millionViewListenView Earnings Details
4/29/2015Q115$0.04$0.10$87.30 million$88.70 millionViewListenView Earnings Details
2/4/2015Q414$0.07$0.09$91.80 million$93.50 millionViewListenView Earnings Details
10/30/2014Q314$0.04$0.08$84.40 million$87.10 millionViewListenView Earnings Details
7/31/2014Q214$0.03$0.07$83.30 million$85.40 millionViewListenView Earnings Details
5/1/2014Q114$0.02$0.03$81.10 million$83.00 millionViewListenView Earnings Details
2/5/2014Q413$0.07$0.02$89.98 million$92.60 millionViewListenView Earnings Details
10/30/2013Q3 2013$0.02$0.05$78.85 million$80.35 millionViewN/AView Earnings Details
7/31/2013Q2 2013($0.01)$0.04$78.53 million$79.46 millionViewListenView Earnings Details
4/30/2013Q1 2013($0.02)($0.01)$78.04 million$77.90 millionViewListenView Earnings Details
1/31/2013Q4 2012($0.03)($0.02)$84.06 million$84.40 millionViewListenView Earnings Details
11/5/2012Q312($0.03)($0.03)$84.56 million$79.60 millionViewN/AView Earnings Details
7/31/2012($0.08)($0.02)ViewN/AView Earnings Details
5/3/2012($0.10)($0.06)ViewN/AView Earnings Details
2/8/2012Q4 2011($0.07)($0.21)ViewN/AView Earnings Details
11/2/2011($0.04)($0.10)ViewN/AView Earnings Details
7/27/2011($0.04)($0.05)ViewN/AView Earnings Details
2/2/2011$0.02$0.06ViewN/AView Earnings Details
10/27/2010Q3 2010($0.06)($0.05)ViewN/AView Earnings Details
7/21/2010Q2 2010($0.07)($0.10)ViewN/AView Earnings Details
4/21/2010Q1 2010($0.09)($0.07)ViewN/AView Earnings Details
2/3/2010Q4 2009($0.10)$0.04ViewN/AView Earnings Details
10/21/2009Q3 2009($0.09)($0.13)ViewN/AView Earnings Details
7/22/2009Q2 2009($0.19)($0.13)ViewN/AView Earnings Details
4/22/2009Q1 2009($0.20)($0.34)ViewN/AView Earnings Details
1/28/2009Q4 2008($0.18)($0.95)ViewN/AView Earnings Details
10/23/2008Q3 2008($0.06)($0.17)ViewN/AView Earnings Details
7/24/2008Q2 2008$0.05($0.05)ViewN/AView Earnings Details
4/24/2008Q1 2008($0.01)ViewN/AView Earnings Details
1/31/2008Q4 2007$0.16$0.20ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Affymetrix (NASDAQ:AFFX) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Affymetrix (NASDAQ:AFFX)

No dividend announcements for this company have been tracked by

Insider Trades

Affymetrix (NASDAQ AFFX) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Affymetrix (NASDAQ:AFFX)
Institutional Ownership by Quarter for Affymetrix (NASDAQ:AFFX)

Affymetrix (NASDAQ AFFX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2015Robert H TriceDirectorSell2,500$9.40$23,500.0047,278View SEC Filing  
11/17/2015Robert H TriceDirectorSell2,500$9.00$22,500.0047,278View SEC Filing  
10/15/2015Robert H TriceDirectorSell2,500$9.00$22,500.0047,278View SEC Filing  
7/20/2015Frank WitneyCEOSell37,991$11.20$425,499.20View SEC Filing  
7/10/2015Frank WitneyCEOSell62,756$11.00$690,316.00View SEC Filing  
6/26/2015Frank WitneyCEOSell75,000$11.22$841,500.00View SEC Filing  
6/22/2015David A WeberEVPSell33,879$12.00$406,548.00View SEC Filing  
6/19/2015David A WeberEVPSell14,760$12.00$177,120.00View SEC Filing  
6/4/2015Frank WitneyCEOSell75,000$11.78$883,500.00View SEC Filing  
2/17/2015Gavin WoodCFOSell1,300$11.40$14,820.00View SEC Filing  
1/20/2015Gavin WoodCFOSell22,500$11.77$264,825.00View SEC Filing  
1/12/2015Gavin WoodCFOSell10,200$10.77$109,854.00View SEC Filing  
12/29/2014Gavin WoodCFOSell18,734$10.20$191,086.80View SEC Filing  
11/19/2013Robert TriceDirectorSell6,205$7.98$49,515.9053,199View SEC Filing  
8/21/2012Timothy C BarabeCFOBuy10,000$3.75$37,500.00View SEC Filing  
8/17/2012Timothy C BarabeCFOBuy5,550$3.99$22,144.50View SEC Filing  
8/13/2012Timothy C BarabeCFOBuy4,450$3.99$17,755.50View SEC Filing  
(Data available from 1/1/2013 forward)


Affymetrix (NASDAQ AFFX) News Headlines

Affymetrix (AFFX) versus Digiliti Money Group (DGLT) Critical ComparisonAffymetrix (AFFX) versus Digiliti Money Group (DGLT) Critical Comparison - December 11 at 11:24 AM
Comparing Affymetrix (AFFX) & Digiliti Money (DGLT)Comparing Affymetrix (AFFX) & Digiliti Money (DGLT) - November 26 at 1:16 AM
Affymetrix (AFFX) versus Digiliti Money (DGLT) Critical ContrastAffymetrix (AFFX) versus Digiliti Money (DGLT) Critical Contrast - November 24 at 1:24 AM
Analyzing Lion Biotechnologies (IOVA) & Affymetrix (AFFX)Analyzing Lion Biotechnologies (IOVA) & Affymetrix (AFFX) - November 19 at 5:06 PM
Comparing Invitae Corporation (NVTA) and Affymetrix (AFFX)Comparing Invitae Corporation (NVTA) and Affymetrix (AFFX) - November 18 at 1:32 PM
CareDx (CDNA) versus Affymetrix (AFFX) Financial AnalysisCareDx (CDNA) versus Affymetrix (AFFX) Financial Analysis - October 28 at 11:42 AM
Contrasting CareDx (CDNA) and Affymetrix (AFFX)Contrasting CareDx (CDNA) and Affymetrix (AFFX) - October 27 at 3:06 AM
Head-To-Head Analysis: Affymetrix (AFFX) vs. CareDx (CDNA)Head-To-Head Analysis: Affymetrix (AFFX) vs. CareDx (CDNA) - September 30 at 6:26 AM
Luminex Partners Sutter Health to Boost Molecular TestingLuminex Partners Sutter Health to Boost Molecular Testing - August 30 at 3:44 PM
Veracyte (VCYT) and Affymetrix (AFFX) Financial ContrastVeracyte (VCYT) and Affymetrix (AFFX) Financial Contrast - August 24 at 4:24 PM
DIGILITI MONEY (DGLT) & Affymetrix (AFFX) Critical SurveyDIGILITI MONEY (DGLT) & Affymetrix (AFFX) Critical Survey - July 14 at 12:54 PM
Form N-PX CAPSTONE SERIES FUND For: Jun 30 - StreetInsider.comForm N-PX CAPSTONE SERIES FUND For: Jun 30 - - July 29 at 3:20 PM
Larry Robbins Largest –st-Quarter SalesLarry Robbins' Largest –st-Quarter Sales - June 10 at 9:01 PM
Thermo Fisher Demonstrates Impressive QuarterThermo Fisher Demonstrates Impressive Quarter - April 28 at 10:42 AM
Affymetrix (AFFX) Stock Retreats After Origin Withdraws Takeover BidAffymetrix (AFFX) Stock Retreats After Origin Withdraws Takeover Bid - March 29 at 9:55 AM

SEC Filings

Affymetrix (NASDAQ:AFFX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Affymetrix (NASDAQ:AFFX) Income Statement, Balance Sheet and Cash Flow Statement


Affymetrix (NASDAQ AFFX) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.